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Perinatal mental health research and clinical practice has 
disproportionately targeted depression (Dennis et al., 2017), despite 
a significant comorbidity with anxiety (Falah-Hassani et al., 2016). 
Today, existing data suggest that anxiety across pregnancy is highly 
prevalent and deserves clinical attention similar to that given to 
depression. In this sense, in the systematic review and meta-analysis 
carried out by Dennis et al. (2017) it was found that prevalence of self-
report anxiety symptoms was 18.2% in the first-, 19.1% in the second-, 
and 24.6% in the third trimester of pregnancy. The overall prevalence 
for anxiety symptoms across the three trimesters was 22.9%. In Spain, 
Soto-Balbuena et al. (2018) using Spitzer et al.’s (2006) GAD-7, a 
general anxiety scale, found a prevalence of anxiety during pregnancy 
of 19.5%, 16.8%, and 17.2% in the first-, second-, and third trimesters, 
respectively. It should be noted that women may experience specific 
fears during pregnancy, such as fear of incompetence as mother, pain 
after birth, loss of own life and the baby’s life, and worries about 
physical, personal, and marital changes due to pregnancy and birth 
(Huizink et al., 2004).
The relevance of evaluating perinatal anxiety is due to its comorbidity 
with depression and its impact on both the mother and her offspring. The 
presence of anxiety and depression during pregnancy represents a risk 
factor that increases the chance of developing postpartum depression 
(Míguez et al., 2017). Furthermore, obstetrically, pregnancy-related 
anxiety has been associated with premature birth, longer duration of 
labor, greater probability of using analgesics, and low weight at birth 
(Dunkel Schetter & Tanner, 2012). Pregnancy-related anxiety has also 
been associated with consequences such as depression and anxiety in 
descendants at 14 and 15 years of age (Van den Bergh et al., 2008), and 
attention deficit and hyperactivity disorder among descendants aged 8 
and 9 years (Van den Bergh & Marcoen, 2004).
The adverse outcomes associated with pregnancy-related 
anxiety demonstrate the need to carry out adequate and specific 
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A B S T R A C T
The aim of this study is to obtain a Spanish brief version of the Pregnancy Related Anxiety Questionnaire and analyse its 
psychometric properties. A longitudinal study was carried out on a sample of 569 Spanish pregnant women with normal 
risk status. Participants were assessed in the first, second, and third trimesters of pregnancy by using a socio-demographic 
and obstetric-gynaecological questionnaire, the PRAQ-55, the Edinburgh Postnatal Depression Scale, and the State-Trait 
Anxiety Inventory. PRAQ-55 items with factorial loads > .50 were selected resulting in a final scale of 20 items. A cut-off 
point ≥ 67 (85th percentile) was used to identify women with high pregnancy-specific anxiety. The findings revealed 
that PRAQ-20 can be considered a useful screening tool in clinical practice to assess pregnancy-related anxiety in both 
nulliparous and multiparous pregnant women. 
Versión española abreviada del cuestionario de ansiedad relacionada con el 
embarazo
R E S U M E N
El objetivo de este estudio es obtener una versión breve en español del Cuestionario de Ansiedad Relacionada con el Embarazo 
y analizar sus propiedades psicométricas. Se realizó un estudio longitudinal en una muestra de 569 mujeres embarazadas 
españolas con un embarazo de riesgo normal. Se evaluó a las participantes en el primer, segundo y tercer trimestre de 
embarazo utilizando un cuestionario sociodemográfico y obstétrico-ginecológico, el PRAQ-55, la Escala de Depresión 
Postparto de Edimburgo y el Inventario de Ansiedad de Estado-Rasgo. Se seleccionaron los ítems de la PRAQ-55 con cargas 
factoriales > .50, lo que dio como resultado una escala final de 20 ítems. Se utilizó como punto de corte 67 (percentil 85) 
para identificar a aquellas mujeres con elevada ansiedad específica del embarazo. Los resultados mostraron que el PRAQ-
20 puede considerarse una herramienta de cribado útil en la práctica clínica para evaluar la ansiedad relacionada con el 
embarazo tanto en mujeres embarazadas nulíparas como multíparas.
Palabras clave:







16 M. B. Vázquez and M. C. Míguez / Clínica y Salud (2021) 32(1) 15-21
assessments. However, in both clinical practice and research these 
specific fears and concerns are not taken into account by general 
anxiety evaluation scales. One of the most commonly used measures 
to assess perinatal anxiety is the State-Trait Anxiety Inventory (STAI; 
Spielberger et al., 1970). As a consequence, they may not detect 
every woman that actually experiences high levels of anxiety in this 
period of life. The results derived from the use of general scales could 
therefore be underestimating its prevalence. On the other hand, they 
may also include false positive rates due to the ambiguity of some 
items for pregnant women. That is, some items in general anxiety 
scales have somatic contents, such as nausea or fatigue, which are 
common symptoms experienced by many pregnant women, and 
may lead to misclassification of certain women (Brunton et al., 
2015). Likewise, pregnancy-specific anxiety is a robust predictor 
of birth-related and childhood outcomes, independent of general 
anxiety measures (Dunkel Schetter & Tanner, 2012; Reck et al., 2013).
Therefore, there is a need to develop valid and reliable tools to 
screen pregnancy-specific anxiety (Askarizadeh et al., 2017), such as 
the Pregnancy Related Anxiety Questionnaire (PRAQ). The original 
version of the PRAQ is made up of 55 items and was developed in The 
Netherlands (Van den Bergh, 1990). It has been adapted and used 
in different countries (e.g., Aksoy-Derya et al., 2018; Askarizadeh 
et al., 2017). Huizink et al. (2004) proposed a reduced version of 
10 items with three factors instead of the original five-factor scale, 
which resulted in a significant loss of information in this regard. In 
Spain, Vázquez et al. (2018) carried out the adaptation of the PRAQ 
in its original version. PRAQ shown good psychometric properties 
and proved to be a valid measurement of pregnancy-specific 
anxiety. However, despite the utility of this scale, the large number 
of items of the PRAQ-55 could make the scale difficult to use in 
clinical practice. Furthermore, the sample was circumscribed to the 
first trimester of pregnancy and only included nulliparous women. 
Therefore, the results cannot be generalised to all pregnant women, 
since pregnant women’s concerns may be different in each trimester 
and the prevalence of anxiety varies throughout pregnancy (Matthey 
& Ross-Hamid, 2012).
In view of these data, the aims of the present study were to obtain 
a brief Spanish version of the PRAQ-55 to be administered to all 
pregnant women across all trimesters of pregnancy and to assess the 
instrument’s validity and reliability.
Method
Participants
The study sample consisted of 569 pregnant women who 
completed the questionnaires in each trimester of their pregnancy. 
In the first trimester of pregnancy, sample’s age ranged from 18 to 
45 years (M = 32.80, SD = 4.75). The majority of the participants 
were married or lived with their partner (94.9%) and 46.4% of them 
had university studies. Concerning their employment situation, 
75.0% of the sample were employed. Regarding parity, 59.4% were 
primiparous and 40.6% were multiparous. Pregnancy was planned 
in 85.9% of cases.
Instruments
Socio-demographic and obstetric-gynaecological questionnai-
re. An ad hoc questionnaire was built for this study, which included 
information about socio-demographic variables (e.g., age, marital 
status, educational level, occupational status, and personal monthly 
income), previous obstetrical history and current pregnancy (e.g., 
number of previous pregnancies, planned pregnancy, complications, 
etc.). Additionally, information about psychopathological disorders 
and psychological/pharmacological treatment was collected.
Pregnancy Related Anxiety Questionnaire-55 (PRAQ-55; Van 
den Bergh, 1990). PRAQ-55 is a scale that refers to specific fears and 
worries related to pregnancy and describes how a woman feels at 
that moment. The original version consisted of 55 items and seven 
response options, distributed in five subscales (1: concern for 
changes in oneself and in relationships; 2: fear for the integrity of the 
baby; 3: feelings about oneself; 4: fear of childbirth; and 5: concerns 
about the future and ability as a mother). In the present study, the 
Spanish version (Vázquez et al., 2018) was used. Nevertheless, in 
order to facilitate the scale’s clinical usefulness, response options 
were reduced from 7 to 5. In this way, item responses use a 5-point 
scale (1 = nothing, 2 = almost nothing, 3 = something, 4 = quite, 5 = 
much). Therefore, the total score can range from 55 to 275, so that the 
higher the score, the higher the pregnancy-related anxiety. Based on 
previous studies (Matthey et al., 2013; Witteveen et al., 2016), PRAQ 
total score’ 85th percentile was used to identify women with high 
scores on pregnancy-related anxiety. Finally, this questionnaire was 
initially created to be used with nulliparous women due to item 35 
content, “I am afraid of the labor, because I have never been through 
it before, I am afraid of the unknown”. To overcome this limitation 
certain authors removed (Aksoy-Derya et al., 2018; Koelewijn et 
al., 2017; Westerneng et al., 2015) or modified (Fontein-Kuipers et 
al., 2015; Huizink et al., 2015; Mudra et al., 2019) this item when 
evaluating multiparous women. However, studies often use this item 
without any change in both nulliparous and multiparous women 
(Askarizadeh et al., 2017; Dubber et al., 2015; Matthey et al., 2013; 
Van Bussel et al., 2010). In this study, item 35 second part, “because 
I have never been through it before, I am afraid of the unknown” 
was removed to facilitate interpretation regardless of parity. In this 
sample, PRAQ-55 reliability was .97 in first-, second-, and third 
trimester of pregnancy.
Edinburgh Postnatal Depression Scale (EPDS). EPDS (Cox et al., 1987) 
is a self-reported questionnaire designed to detect depressive symptoms, 
asking about how women have been feeling over the past 7 days. This 
scale includes 10 items with four response choices, each of them having 
a single value between 0 and 3. The higher the value, the more severe 
the symptom. The present study used the Spanish version of the EPDS 
(Vázquez & Míguez, 2019), which showed good internal consistency in 
first- (α = .81), second- (α = .82), and third trimester (α = .85). 
State-Trait Anxiety Inventory (STAI). STAI (Spielberger et al., 
1970; Spanish version: TEA, 1982) consists of two self-reported 
scales to measure two distinct anxiety concepts: state-anxiety 
and trait-anxiety. Both scales contain 20 statements, rated on a 
4-point Likert scale that prompts the respondent to describe how 
she currently feels (state-anxiety) or how she generally feels (trait-
anxiety). For example, the state-anxiety items could be 0 = not at all, 
1 = somewhat, 2 = moderately so, 3 = very much so. The total score 
ranges between 0 and 60, in such a way that the higher the score, the 
higher the level of anxiety. The cut-off point used for state-anxiety 
was 32 or more, which corresponds to the 75th percentile to screen 
high anxiety in women. In this sample, reliability of the state-anxiety 
scale was .91 in first trimester and .92 in second and third trimesters 
of pregnancy, respectively. Reliability of the trait-anxiety scale was 
.88 in first trimester.
Procedure
The sample was recruited in their first trimester of pregnancy 
in the obstetric control visit to the reference hospital (northwest 
of Spain). Pregnant women were invited to participate in this 
longitudinal study which took place from September 2015 to July 
2017. Inclusion criteria were the following: being 18 years of age 
or older, participating voluntarily in the study, and speaking and 
reading Spanish. From the 620 women evaluated in first trimester, 
33 had an early miscarriage, 7 had a preterm birth, and 11 did not 
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want to participate in the study. The study sample was made up 
of 569 pregnant women with a normal risk status, who completed 
the questionnaires in all three trimesters of their pregnancy. 
Participation rate in the study was 91.8%.
Written informed consent was obtained from all subjects. 
Individual administration of the different questionnaires (paper 
and pencil) were carried out by one psychologist in first trimester 
of pregnancy (T1), between 8th and 14th week of pregnancy (M 
=10.87, SD = 2.36); in second trimester of pregnancy (T2), between 
20th and 24th week (M = 20.70, SD = 1.22); and in third trimester of 
pregnancy (T3), between 32th and 36th week (M = 34.64, SD = 1.26). 
In each pregnancy trimester, all the questionnaires were provided 
during routine prenatal appointments. Average evaluation time was 
30 minutes in each trimester. Participants did not get any type of 
incentive for their participation.
This study was reviewed and approved by the Clinical Research 
Ethics Committee of Galicia, Spain, and has therefore been 
performed in accordance with the ethical standards laid down in the 
Declaration of Helsinki 1964 and later amendments.
Statistical and Psychometric Analysis
PRAQ-20 factor structure was examined by means of exploratory 
(EFA) and confirmatory (CFA) factor analysis using SPSS v22 for 
Windows and FACTOR v10 program, respectively. Specifically, our 
shortened 20-item version, the PRAQ-20, was derived from the 
Spanish version (Vázquez et al., 2018) by retaining items with the 
highest factor loadings in the three trimesters of pregnancy on 
each of the five subscales. In this study the criterion used to retain 
items in each factor was a score > .50 in the factorial load. This 
procedure was repeated in each trimester of pregnancy with the 
aim of checking whether the scale’s factor structure remains stable 
regardless of the time of evaluation of pregnancy-related anxiety. 
EFA was performed to determine whether the PRAQ-20 shows a 
similar factor structure in our sample to that found by Vázquez et 
al. (2018). Particularly, Kaiser-Meyer-Olkin (KMO) test of sampling 
adequacy and Bartlett’s sphericity test was performed to show 
the data as suitable. Method for factor extraction was Unweighted 
Least Squares (ULS) and the criterion for determining the number 
of factors was the Parallel Analysis (PA). Then, factor analysis was 
carried out to calculate the rotated principal component matrix 
using Oblimin method.
CFA was performed to obtain goodness of fit measures. Model fit 
was assessed using a combination of fit indices: chi-square divided 
by degrees of freedom (c2/df), Comparative Fit Index (CFI), Goodness 
of Fit Index (GFI), Root Mean Square Error of Approximation (RMSEA) 
and Standardized Root Mean Square Residual (SRMR). When chi-
square is divided by its degrees of freedom the result should be less 
than 6 if it is to indicate a reasonable fit to the data (Kline, 2011). Other 
fit criteria include CFI and GFI values greater than. 95 are indicative 
of good model fit (Hu & Bentler, 1999), whereas SRMR values lower 
than. 08, and RMSEA values lower than. 06 are considered good 
fitting models (MacCallum et al., 1996).
Additionally, Cronbach’s α was calculated to determine PRAQ-20 
internal consistency reliability, and concurrent validity coefficients 
were calculated using Pearson correlation.
To establish PRAQ cut-off point, scale’s percentiles were 
calculated. The 85th percentile was used to identify women with 
high pregnancy-specific anxiety. On the other hand, prevalence of 
general anxiety assessed with STAI and pregnancy-related anxiety 
assessed with PRAQ was estimated. Finally, differences between 
prevalence obtained with each of the anxiety scales were analyzed 
with the Pearson’s chi-square statistic.
In this research, a p-value <.05 was considered significant.
Results
Construct Validity
The analysis revealed a Kaiser-Meyer-Olkin (KMO) index of .91 
in first-, .92 in second-, and. 93 in third trimester of pregnancy, 
respectively, and a statistically significant Bartlett’s test (< .001). 
EFA results for this scale support a model consisting of five factors: 
factor 1, “concern for changes in oneself”, is made up of items 15, 31, 
44; factor 2, “fear for the baby’s integrity”, composed of items 5, 6, 7, 
8, 9, 11, 21; factor 3, “feelings about oneself” composed of items 25, 27, 
28; factor 4 “fear of childbirth”, made up of items 10, 35, 36, 37; factor 
5, “concern about the future”, composed of items 40, 42, 53. The same 
model is obtained in each trimester of pregnancy with a variance 
explained of 67.97%, 72.29%, and 72.98%, respectively (Table 1).
For data of first trimester of pregnancy, the following fit index 
values were found after CFA: c2/df = 0.97, RMSEA = .00, SRMR = .02, GFI 
= .99, CFI = .99. For data of second and third trimester of pregnancy, 
the following fit index values were found: c2/df = 0.97, RMSEA = .0, 
SRMR = .02, GFI = .99, and CFI = 1.0.
Reliability
In this sample, the reliability of the total PRAQ-20 scale was .91 
in first trimester and .93 in second and third trimesters, respecti-
vely. Reliability of factors ranged from .71 to .94. Reliability of the 
total PRAQ-20 scale in nulliparous women was .92 in first trimester 
and .93 in the second and third trimesters, respectively. Concerning 
multiparous women, reliability was .90 in first trimester and .93 
in second and third trimesters, respectively. Reliability of factors 
in nulliparous women ranged from .74 to .94 and in multiparous 
women ranged from .54 to .94 (Table 1).
Concurrent Validity
Table 2 summarizes PRAQ-20 concurrent validity, which was 
evaluated by correlating PRAQ measures with STAI and EPDS in first-, 
second-, and third trimester. Correlation between EPDS, state-STAI, 
and trait-STAI with both total PRAQ and each of the factors ranged 
from .25 to .47 in first trimester, from .30 to .53 in second- and 
from .34 to .56 in third trimester, respectively. On the other hand, 
correlation of different factors among themselves, as well as with the 
total PRAQ ranged from .29 to .85 in first trimester, from .35 to .88 in 
second- and from .34 to .88 in third trimester, respectively.
On the other hand, Table 3 summarizes the correlation of PRAQ-
20 with PRAQ-55 in first-, second-, and third trimester. Correlation 
between PRAQ-20 and both total PRAQ-55 and each of the factors 
ranged from .33 to .98 in first trimester, from .40 to .99 in second-, 
and from .43 to .99 in third trimester, respectively.
Pregnancy-related Anxiety with PRAQ-55 and PRAQ-20 vs 
General Anxiety
Average PRAQ-55 scores for each trimester of pregnancy were 
122.48 (SD = 41.71), 117.59 (SD = 44.02), and 116.96 (SD = 43.95), 
respectively. Concerning the PRAQ-20, average scores were 50.66 
(SD = 16.76) in first trimester, 47.37 (SD = 17.93) in second trimester, 
and 44.68 (SD = 18.02) in third trimester. Finally, average STAI scores 
were 16.96 (SD = 10.25), 14.29 (SD = 9.02), and 15.94 (SD = 9.87), 
respectively.
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Figure 1 shows prevalence of pregnancy-related anxiety with 
PRAQ-55 considering a cut-off point ≥ 165 and with PRAQ-20 
considering a cut-off point ≥ 67. Likewise, prevalence of general 
anxiety with STAI-state was obtained considering a cut-off point 
≥ 32.
Difference in prevalence between pregnancy-related anxiety 
(PRAQ-55) and general anxiety (STAI) was statistically significant 
in first- (c² = 2.91, p = .004, Cramer’s V = .22), second- (c² = 5.62, 
p < .001, Cramer’s V = .16), and third trimester of pregnancy (c² 
= 3.40, p < .001, Cramer’s V = .27). In particular, prevalence of 
pregnancy-related anxiety with PRAQ-55 was higher than general 
anxiety.
Likewise, difference in prevalence between pregnancy-related 
anxiety (PRAQ-20) and general anxiety (STAI) was statistically 
significant in first- (c² = 3.84, p < .001, Cramer V = .24), second- (c² 
= 5.99, p < .001, Cramer’s V = .17), and third trimester of pregnancy 
(c² = 2.71, p = .006, Cramer’s V = .31). Specifically, prevalence of 
pregnancy-related anxiety with PRAQ-20 was higher than general 
anxiety.
Finally, prevalence found between PRAQ-55 and PRAQ-20 was 
not statistically significant in either first- (c² = 0.87, p = .386), 
second- (c² = 0.32, p = .747), or third trimester of pregnancy (c² = 
0.62, p = .535).
Table 1. Structure Matrix Correlations of the CFA and Reliability for the PRAQ-20
1st Trimester 2nd Trimester 3º Trimester
1 2 3 4 5 1 2 3 4 5 1 2 3 4 5
5.  Tengo miedo de que mi bebé sufra algún daño cerebral o discapacidad mental 
(I am afraid that my baby will be brain damaged or lacking in mental capacity).
.834 .813 .835
6.  Temo que los movimientos del feto o la ausencia de ellos sean anormales (I 
fear that the movements or non-movements of my fetus are abnormal).
.774 .795 .757
7.  Tengo miedo de que mi bebé muera después de nacer (I fear that my baby will 
die after birth).
.811 .866 .885
8.  Aunque conozco los avances médicos en relación al parto temo que pueda 
morir durante el mismo (I am afraid that I might die during childbirth, even 
though I recognize medical advancements in this area).
.701 .764 .798
9.  Temo que mi feto tenga alguna malformación (I fear that my fetus is malformed 
or deformed).
.850 .879 .886
10.  Me da miedo el dolor durante la dilatación y el parto (I fear the pain during 
labor and delivery).
.308 .692 .707 .370 .631
11.  Tengo miedo a la muerte y a la pérdida de un ser querido (I am afraid of the 
death and resulting loss of a loved one).
.536 .664 .314 .703
15.  Me preocupa que mi cuerpo no recupere su figura habitual después del 
embarazo (I am concerned that my body will not regain its normal shape after 
the conclusion of pregnancy).
.767 .814 .785
21.  Temo que mi bebé no esté sano (I am afraid that my baby will not be healthy) .804 .821 .798
25.  Me preocupan mis cambios repentinos de humor (I am concerned about my 
sudden mood changes).
.742 .814 .807
27.  Me preocupa convertirme en una persona demasiado centrada en mí misma 
(I am concerned about becoming pre-occupied with myself, and feel that I 
might be turning inward).
.759 .630 .422 .677 .356
28.  Me preocupa mi irritabilidad (I am concerned about my irritability) .811 .825 .814
31.  Estoy preocupada por mi aspecto físico poco atractivo (I am concerned about 
my unattractive physical appearance).
.747 .712 .374 .743 .340
35.  Tengo miedo al parto (I am afraid of the labour). .831 .842 .834
36.  Me preocupa que pueda gritar y perder el control durante el parto (I am 
worried that I might shout and scream during labour, that I might lose control 
of myself).
.784 .746 .300 .782
37.  Me da miedo perder mucha sangre durante el parto (I am afraid that I will lose 
a lot of blood during labor).
.354 .331 .627 .408 .612 .381 .667
40. Estoy un poco preocupada por que nuestro bebé pueda no ser guapo y temo 
la reacción de los demás (I am a little worried that our baby might be less 
attractive and I am afraid of the reactions of others).
.738 .731 .686
42.  A veces me preocupa que convertirme en madre me cambie mucho y, por 
ejemplo, me haga sentir mayor (Sometimes I worry that becoming a mother 
will change me a lot and will make me feel old, for example).
.713 .754 .722
44.  Me preocupa haber ganado tanto peso (I worry because I have put on so much 
weight).
.770 .768 .792
53.  Me preocupa que tengamos que renunciar a muchas cosas por el bebé (I am a 
bit afraid that we will have to give up a lot of things for the baby).
.707 .379 .690 .745
Cronbach’s α
Total sample (N = 569)
.78 .91 .82 .83 .71 .83 .94 .82 .83 .74 .83 .94 .84 .85 .73
.91 .93 .93
Nulliparous (n = 338)
.76 .90 .82 .85 .74 .81 .93 .84 .85 .76 .84 .94 .84 .88 .74
.92 .93 .93
Multiparous (n = 231)
.81 .91 .82 .69 .54 .85 .94 .80 .78 .70 .84 .94 .83 .77 .71
.90 .93 .93
% Variance explained 67.97 72.29 72.98
Note. Factor 1 = concern for changes in oneself; factor 2 = fear for the integrity of the baby; factor 3 = feelings about oneself; factor 4 = fear of childbirth; factor 5 = concern about 
the future. 
Values < .30 were deleted.



















First Trimester Second Trimester Third Trimester
PRAQ-55 PRAQ-20 STAI
Figure 1. Prevalence Pregnancy-specific Anxiety with PRAQ-55 and PRAQ-20 
and Prevalence General Anxiety with STAI, in each Trimester of Pregnancy.
Discussion
A longitudinal study of a large sample of 569 pregnant women 
was carried out to get a Spanish brief version of PRAQ, as well as to 
analyse its psychometric properties. The results revealed that PRAQ-
20 could be a suitable tool for screening pregnancy-specific anxiety, 
regardless of parity, in Spanish pregnant women.
Regarding PRAQ-20 construct validity, findings were consistent 
with results of the Spanish PRAQ-55 version (Vázquez et al., 2018) 
and the Spanish brief version is also structured across five factors. 
However, factor 1 lost the second part of its statement “…and in 
relationships” to better adjust to the items that are finally part of it 
(15, 31, 44). Similarly, items 40, 42, and 44, which were previously 
part of factor 1 (Vázquez et al., 2018), now make up factor 5. It should 
be noted that this same structure remained constant in the three 
trimesters of pregnancy. After conducting factor analyses, the same 
structure has been kept as in the Spanish validation of the scale 
(Vázquez et al., 2018), where only nulliparous women were included. 
This fact could indicate that the scale behaves the same way with 
both nulliparous and multiparous women. This would facilitate the 
usefulness of the scale, since no distinction should be made between 
both groups of women when administering the questionnaire. On 
the other hand, correlations between PRAQ-20 and PRAQ-55 were 
high when comparing same factors (specifically factors 1, 2, 3, and 4) 
of both scales with each other (ranged from.77 to .99). Correlations 
were also high when comparing total scores of both scales with each 
of the factors (ranged from .70 to .96). This data would justify the 
use of PRAQ-20 as a tool equivalent to PRAQ-55. Concerning factor 
5, correlations are lower in all cases (ranging from .54 to .70). This is 
due to the fact that factor 5 items are not the same in both scales, as 
most were removed.
On the other hand, CFA supported five-factor scale structure 
yielded by EFA and goodness of fit measures revealed a good fit of 
the model. It should be noted that, despite the existence of a smaller 
version such as PRAQ-10 (Huizink et al., 2004), a version of 20 items 
was validated due to the fact that in PRAQ-10 all the items of factor 3 
(feelings about oneself) and factor 5 (concern about the future) of the 
original version of 55 items are lost. Therefore, relevant information 
could have been lost. 
In terms of concurrent validity, results obtained show moderate 
correlations among total PRAQ scale, EPDS, and STAI. Likewise, in 
terms of anxiety, these data would be consistent with other study 
(Huizink et al., 2004) which discovered that only about 8-27% 
of pregnancy-related anxiety variance was explained by general 
anxiety, concluding that both general and pregnancy-related anxiety 
should be taken into account as distinct, i.e., complementary and 










EPDS 1 .66** .71** .35** .36** .41** .25** .30** .44**
State Anxiety 1 .51** .34** .38** .36** .29** .33** .46**
Trait Anxiety 1 .42** .41** .43** .31** .35** .47**
Factor 1 1 .34** .48** .38** .54** .64**
Factor 2 1 .46** .50** .29** .85**
Factor 3 1 .47** .41** .72**
Factor 4 1 .44** .77**
Factor 5 1 .59**
2nd Trimester
EPDS 1 .67** .65** .38** .46** .51** .34** .33** .53**
State Anxiety 1 .60** .34** .41** .48** .35** .37** .50**
Trait Anxiety 1 .39** .43** .45** .36** .30** .51**
Factor 1 1 .43** .56** .42** .54** .69**
Factor 2 1 .48** .58** .35** .88**
Factor 3 1 .43** .53** .71**
Factor 4 1 .44** .78**
Factor 5 1 .62**
3rd Trimester
EPDS 1 .67** .63** .40** .47** .56** .40** .35** .56**
State Anxiety 1 .60** .37** .44** .52** .42** .37** .54**
Trait Anxiety 1 .36** .42** .48** .35** .34** .50**
Factor 1 1 .39** .54** .48** .59** .68**
Factor 2 1 .51** .59** .34** .88**
Factor 3 1 .48** .53** .73**
Factor 4 1 .49** .80**
Factor 5 1 .63**
Note. Factor 1 = concern for changes in oneself; factor 2 = fear for the integrity of the baby; factor 3 = feelings about oneself; factor 4 = fear of childbirth; factor 5 = concern about 
the future.
**p < .001.
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non-exclusive entities. Similarly, accumulating evidence confirmed 
that pregnancy-related anxiety is a distinct anxiety type (Anderson 
et al., 2018).
Total PRAQ-20 scale reliability in each trimester of pregnancy 
was excellent. Likewise, Cronbach’s α of five factors is considered 
between acceptable and excellent. This shows that it is an instrument 
that presents good internal consistency, both at general level and in 
subscales.
In this research, the difference between prevalence found with 
PRAQ-55 and PRAQ-20 was not statistically significant. Therefore, it 
could be stated that, despite reduction in the number of items, PRAQ-
20 could be valid for identifying women with pregnancy-related 
anxiety. In this way, it facilitates even more the application of the 
scale in clinical practice, as it reduces time needed to carry out the 
evaluation in less than five minutes. On the other hand, statistically 
significant differences were found between prevalence reported with 
PRAQ (PRAQ-55 and PRAQ-20) and prevalence obtained with STAI. 
These results are consistent with those found in the adaptation of 
PRAQ-55 (Vázquez et al., 2018) and would continue to corroborate two 
hypotheses proposed by Huizink et al. (2004): on the one hand, data 
about pregnancy-related anxiety prevalence obtained with general 
anxiety scales could be underscoring the real number of women with 
high anxiety levels during pregnancy; on the other hand, it would be 
confirmed that general anxiety and pregnancy-related anxiety could 
be different entities.
The prevalence of pregnancy-specific anxiety in this study using 
the 85th percentile, in both PRAQ-55 and PRAQ-20, ranged from 12.1% 
to 18.1%. Other authors (Fontein-Kuipers et al., 2015; Koelewijn et al., 
2017) found a prevalence of 11% and 30.8%, respectively, although 
they do not provide data per trimester, only on overall pregnancy. 
Therefore, they have not taken into account that the trajectory of 
prevalence of anxiety varies in each trimester of pregnancy. The 
trajectory of pregnancy-specific anxiety in this study, with both 
PRAQ-55 and PRAQ-20 questionnaires, decreases from first trimester 
(16.0% and 18.0%) to third trimester (13.5% and 12.1%). One possible 
explanation for this downward trajectory could be that specific fears 
and concerns decrease throughout the weeks of pregnancy because 
women adapt themselves to their new situation, receive information, 
and have more knowledge about the entire process of pregnancy and 
childbirth. In this sense, many women attend maternal education 
sessions in third trimester aimed to diminish fears and concerns 
of pregnant women concerning childbirth and postpartum period. 
As a consequence, participation in maternal education sessions 
should be encouraged, since it would allow for the detection and 
implementation of interventions in order to reduce anxiety.
The most important strength of this study is that it is the first to 
use PRAQ in Spain in a large sample of pregnant women to evaluate 
pregnancy-related anxiety in each trimester of pregnancy. The 
reduction in the number of items, as well as the possibility of being 
used at any time in pregnancy with both nulliparous and multiparous 
women makes PRAQ-20 a useful scale in daily clinical practice to 
detect women with pregnancy-specific anxiety versus general anxiety 
scales. A limitation is that we need to be cautious when considering 
the cut-off point used, as having a clinical interview would be ideal. 
Furthermore, discriminant validity of the measure has not been 
analysed, and all the women from the sample were from the same 
geographical area in Spain. 
The Spanish brief version of the Pregnancy Related Anxiety 
Questionnaire (PRAQ-20) would be made up of 20 items, divided 
into five factors, with five response choices, each of them having 
a single value ranging from 1 to 5. As a consequence, total score 
can vary between 20 and 100, so the higher the score, the higher 
the level of pregnancy-specific anxiety. A cut-off point ≥ 67 (85th 
percentile) was used to detect women with high levels of pregnancy-
Table 3. Correlations of the PRAQ-20 and PRAQ-55 by Trimester of Pregnancy
PRAQ-55
Pearson Correlation Factor 1 Factor 2 Factor 3 Factor 4 Factor 5 Total
1st Trimester PRAQ-20
Factor 1 .77** .40** .56** .46** .52** .66**
Factor 2 .51** .98** .62** .64** .58** .77**
Factor 3 .67** .56** .90** .60** .58
**
.77**
Factor 4 .59** .55** .38** .92** .58
**
.74**
Factor 5 .80** .33** .50** .48** .54** .64**
Total .81** .87** .82** .85** .74** .95**
2nd Trimester PRAQ-20
Factor 1 .81** .49** .62** .52** .56** .70**
Factor 2 .56** .99** .65** .72** .60** .80**
Factor 3 .76** .57** .90** .57** .65** .79**
Factor 4 .59** .62** .58** .93** .64** .76**
Factor 5 .81** .40** .58** .49** .59** .67**
Total .83** .90** .83** .87** .77** .96**
3rd Trimester PRAQ-20
Factor 1 .82** .45** .64** .54** .54** .71**
Factor 2 .57** .99** .66** .72** .59** .80**
Factor 3 .76** .58** .92** .60** .63** .79**
Factor 4 .64** .64** .61** .93** .63** .78**
Factor 5 .82** .43** .61** .52** .60** .70**
Total .82** .89** .83** .87** .73** .95**
Note. PRAQ-55. Factor 1 = concern for changes in oneself and in relationships; factor 2 = fear for the integrity of the baby; factor 3 = feelings about oneself; factor 4 = fear of child-
birth; factor 5 = concerns about the future and ability as a mother.
PRAQ-20. Factor 1 = concern for changes in oneself; factor 2 = fear for the integrity of the baby; factor 3 = feelings about oneself; factor 4 = fear of childbirth; factor 5: concern 
about the future. 
**p < .001. 
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specific anxiety. Psychometric properties of PRAQ-20 indicate that 
it could be a useful scale in clinical practice to measure pregnancy-
specific anxiety in Spain. Its use during pregnancy would allow for 
early detection of women with high levels of specific anxiety, thus 
allowing for implementation of interventions according to women’s 
needs, which would contribute to improving prenatal care. It would 
be recommended that all pregnant women are screened for anxiety 
from the first trimester as part of routine care during pregnancy. 
Those who score high on several assessments should be referred to 
mental health services for diagnostic evaluation and treatment if 
necessary. 
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